PACE AS TREATMENT OF RESCUE IN PATIENTS WITH MULTIPLE RELAPSED OR REFRACTORY MYELOMA

被引：0
|
作者：
Isola, I. [1 ]
Granell, M. [2 ]
Marti Josep, M. [3 ]
Gironella, M. [4 ]
Garcia-Guinon, A. [5 ]
Lopez-Pardo, J. [2 ]
Muntanola, A. [3 ]
Abella, E. [6 ]
Motllo, C. [7 ]
Escoda, L. [8 ]
Sierra, J. [2 ]
Blade, J. [1 ]
Rosinol, L. [1 ]
Fernandez de larrea, C. [1 ]
机构：
[1] Hosp Clin Barcelona, Serv Hematol, Unidad Amiloidosis & Mieloma, IDIBAPS, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Serv Hematol, Barcelona, Spain
[3] Hosp Mutua Terrassa, Serv Hematol, Terrassa, Spain
[4] Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain
[5] Hosp Arnau Vilanova, Serv Hematol, Lleida, Spain
[6] Hosp del Mar, Serv Hematol, Barcelona, Spain
[7] Hosp Badalona Germans Trias & Pujol, Serv Hematol, Badalona, Spain
[8] Hosp Joan 23, Serv Hematol, Tarragona, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-070
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [21] Treatment Options for Relapsed and Refractory Multiple Myeloma
    Lonial, Sagar
    Mitsiades, Constantine S.
    Richardson, Paul G.
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1264 - 1277
  • [22] Lenalidomide for the treatment of relapsed or refractory multiple myeloma
    Weber, D. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 22 - 24
  • [23] Elotuzumab in the treatment of relapsed and refractory multiple myeloma
    Grosicki, Sebastian
    Bednarczyk, Martyna
    Barchnicka, Agnieszka
    Grosicka, Olga
    FUTURE ONCOLOGY, 2021, 17 (13) : 1581 - 1591
  • [24] Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
    Bumma, Naresh
    Richter, Joshua
    Jagannath, Sundar
    Lee, Hans C.
    Hoffman, James E.
    Suvannasankha, Attaya
    Zonder, Jeffrey A.
    Shah, Mansi R.
    Lentzsch, Suzanne
    Baz, Rachid
    Maly, Joseph J.
    Namburi, Swathi
    Pianko, Matthew J.
    Ye, Jing Christine
    Wu, Ka Lung
    Silbermann, Rebecca
    Min, Chang-Ki
    Vekemans, Marie-Christiane
    Munder, Markus
    Byun, Ja Min
    Martinez-Lopez, Joaquin
    Cassady, Kaniel
    Deveaux, Michelle
    Chokshi, Dhruti
    Boyapati, Anita
    Hazra, Anasuya
    Yancopoulos, George D.
    Sirulnik, L. Andres
    Lorenc, Karen Rodriguez
    Kroog, Glenn S.
    Houvras, Yariv
    Dhodapkar, Madhav V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (22)
  • [25] Pomalidomide for the treatment of relapsed and refractory multiple myeloma
    Guidetti, Anna
    Prada, Claudia Paba
    Laubach, Jacob P.
    Varga, Cindy
    Maglio, Michelle E.
    McKenney, Mary
    Doss, Deborah
    Schlossman, Robert L.
    Mitsiades, Constantine
    Hideshima, Teru
    Gorgun, Gullu T.
    Ghobrial, Irene M.
    Raje, Noopur
    Munshi, Nikhil
    Anderson, Kenneth C.
    Richardson, Paul G.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (10): : 1089 - 1108
  • [26] Thalidomide for the treatment of relapsed and refractory multiple myeloma
    Cool, RM
    Herrington, JD
    PHARMACOTHERAPY, 2002, 22 (08): : 1019 - 1028
  • [27] Isatuximab for the treatment of relapsed/refractory multiple myeloma
    Richardson, Paul G.
    Beksac, Meral
    Spicka, Ivan
    Mikhael, Joseph
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (12) : 1395 - 1403
  • [28] Treatment options for relapsed and refractory multiple myeloma
    Nooka, Ajay K.
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    Lonial, Sagar
    BLOOD, 2015, 125 (20) : 3085 - 3099
  • [29] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [30] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    European Journal of Medical Research, 15
12345